Podcasts

Episode 37 | Revolutionising Lung Cancer Healthcare with A.I: Unlocking the Future

Thoracic Oncology Group of Australasia podcast, hosted by: Associate Professor Michael Franco, Professor Catherine Jones and Dr Diane Pascoe

Revolutionising lung cancer healthcare with A.I: Unlocking the future

How is Artificial intelligence (AI) transforming medicine?

Lung Cancer healthcare professionals are interested in the use of AI in radiology, particularly in early diagnosis leading to better patient outcomes. In this podcast, we will explore how AI can aid in early detection, accurate interpretation of imaging scans and reduce diagnostic errors.

This episode is hosted by Associate Professor Michael Franco, dual trained in medical oncology and palliative care and the digital health director at Monash in Melbourne. He is joined by Professor Catherine Jones Cardiothoracic Radiologist I-Med Radiology and Clinical Director of Radiology at Redland Hospital, Brisbane and an expert on the Cancer Australia Expert Group for National Lung Cancer Screening Program. And accompanied by Dr Diane Pascoe a Consultant Radiologist and Deputy Director of Medical Imaging at Royal Melbourne Hospital.

Play Episode 37 | Revolutionising Lung Cancer Healthcare with A.I: Unlocking the Future

More Podcasts

In this episode, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Steven Kao discuss the concept of liquid biopsy, its advantages and limitations, and its
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.